Clinical Trial Update: A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia [Phase 1]

View source ↗

Summary

This Phase 1 trial at City of Hope is evaluating a reduced-intensity conditioning regimen of cyclophosphamide, pentostatin, and anti-thymocyte globulin, followe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pentostatin (pentostatin)
• anti-thymocyte globulin (antithymocyte globulin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia | Phase 1 | Status: RECRUITING